Back to search

Article

Precision-cut liver slices as a model for evaluating therapeutic agents against hepatitis B and delta viruses

2025-12-06

Abstract excerpt

<h4>Background: </h4> Developing new therapeutic strategies against hepatitis B virus (HBV) and hepatitis delta virus (HDV) is essential to cure these infections. Yet evaluation of host-targeting agents (HTAs) with in vitro/in vivo models remains challenging. Therefore, we assessed precision-cut liver slices (PCLS) as an HBV/HDV co-infection model to study virus-host interactions and HTAs. <h4>Methods:</h4> We gen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73dca88c-b562-5439-a19a-bb25742ffef5
DOI
10.64898/2025.12.06.692712
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precision-cut liver slices as a model for evaluating therapeutic agents against hepatitis B and delta virusesDOI 10.64898/2025.12.06.692712
Select a neighboring publication to make it the new centre.